Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease

N/AUnknownNCT02062671

Odense University Hospital12 enrolled

Overview

In patients with polycystic kidney disease, pain may be resistant to drug therapy and may reduce quality of life. This study investigate the effect of renal denervation on this pain.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Adult Polycystic Kidney Disease

Interventions

renal denervationPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Pain limiting daily activities in spite of pain killers, ADPKD Exclusion Criteria: * Pregnancy

Locations (1)

Department of Nephrology

Odense, Denmark

RECRUITING

Outcomes

Primary Outcomes

Pain

Pain from VAS

Time frame: 6 months

Secondary Outcomes

Quality of Life (QoL)

SF-12v2

Time frame: 6 months

Central Contacts

Hans Dieperink, MD

CONTACT

+4520598851 hans.dieperink@rsyd.dk

Marie Blicher, MD

CONTACT

+ 45 65415305 marie.blicher@rsyd.dk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.